Vaksin Covid-19: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Maulana.AN (bicara | kontrib)
k Membalikkan revisi 21647328 oleh Donuthere (bicara)
Tag: Pembatalan
InternetArchiveBot (bicara | kontrib)
Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.2
Baris 44:
 
=== Vaksin subunit ===
Vaksin subunit merupakan vaksin yang hanya mengandung satu atau lebih antigen tanpa keseluruhan partikel patogennya. Antigen yang digunakan biasanya merupakan subunit protein, tapi dapat menjadi molekul apapun yang merupakan fragmen dari patogen tersebut.<ref>{{Cite web|title=MODULE 2 – Subunit vaccines - WHO Vaccine Safety Basics|url=https://vaccine-safety-training.org/subunit-vaccines.html|website=vaccine-safety-training.org|access-date=2021-03-25|archive-date=2021-03-20|archive-url=https://web.archive.org/web/20210320163614/https://vaccine-safety-training.org/subunit-vaccines.html|dead-url=yes}}</ref>
 
Pada Januari 2021, satu-satunya vaksin jenis ini yang diotorisasi adalah vaksin peptida EpiVacCorona.<ref>{{Cite journal|last=Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"|date=2021-02-20|title=Simple, Blind, Placebo-controlled, Randomized Study of the Safety, Reactogenicity and Immunogenicity of Vaccine Based on Peptide Antigens for the Prevention of COVID-19 (EpiVacCorona), in Volunteers Aged 18-60 Years (I-II Phase)|url=https://clinicaltrials.gov/ct2/show/NCT04527575}}</ref> Vaksin lainnya yang masih dalam uji klinis termasuk vaksin Novavax<ref>{{Cite journal|last=Novavax|date=2020-10-08|title=A 2-Part, Phase 1/2, Randomized, Observer-Blinded Study To Evaluate The Safety And Immunogenicity Of A SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Or Without MATRIX-M™ Adjuvant In Healthy Subjects|url=https://clinicaltrials.gov/ct2/show/NCT04368988}}</ref> dan RBD-Dimer. Sebelumnya, terdapat vaksin V451 yang sedang diuji klinis, namun dihentikan karena vaksin tersebut dapat menyebabkan hasil yang salah ketika resipien vaksin ini dites HIV.<ref>{{Cite web|title=COVID-19 Vaccine Shelved After False HIV Positives Affirms Need for Multiple Vaccines|url=https://www.biospace.com/article/covid-19-vaccine-scrapped-in-australia-after-producing-false-hiv-positives/|website=BioSpace|language=en-US|access-date=2021-03-25}}</ref>
Baris 263:
Beijing Institute of Biotechnology of the Academy of Military Medical Sciences
|
* Tiongkok (''awal'')<ref>{{Cite news|last=|first=|date=29 Juni 2020|title=CanSino's COVID-19 vaccine approved for military use in China|url=https://asia.nikkei.com/Business/Pharmaceuticals/CanSino-s-COVID-19-vaccine-approved-for-military-use-in-China|work=Nikkei Asia|access-date=15 Januari 2021|archive-date=2021-03-07|archive-url=https://web.archive.org/web/20210307024418/https://asia.nikkei.com/Business/Pharmaceuticals/CanSino-s-COVID-19-vaccine-approved-for-military-use-in-China|dead-url=yes}}</ref>
|
|}